Urethral Cancer Flashcards

1
Q

Incidence

A

Very Rare, <1% of GU malignancy
.
.
50% of patients die of the disease.
M>F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk Factors

A

Chronic inflammation
H/O STD, HPV
Urethritis
Urethral strictres
Urethral Diverticuli
Urinary stasis
Prior XRT
Prior Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anatomy

A

Men: bladder neck to meatus, 20 cms, mostly transitional epithelium, meatus is sq. epithelium
.
.
Females: Shorter, 3-4 cms, 1/3 transitional epithelium 2/3 Sq. epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathology

A

Urothelial Carcinoma 55-65%
SCCa - 15-20%
AdenoCa - rare 10-15% - Skene’s gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical Presentation

A

symptoms of urethral stricture
hematuria
Urethral Discharge
pain
swelling
dyspareunia - females, often mistaken for UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Palpable nodal mets

A

if present will be in inguinal LN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distant Mets

A

10% @ diagnosis
Lung, liver, bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

work up

A

H&P
GU Exam
EUA
to evaluate the extent of disease:
Cystourethroscopy
retrograde urethrogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Labs & Imaging

A

CBC
CMP
Urine Cytology
CT/MRI Pelvis
CT Chest +/- Bone scan
no need PET CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Biopsy

A

Transurethral biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Poor Prognostic Factors

A

Advanced age
Proximal > Distal tumors
Size >2cms
nodes +ve
grade- high
presence of mets obv!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Staging

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

N Staging

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment Paradigm

A

Localized disease: SX, RT-Organ preservation
.
.

Locally Advanced Disease: Neoadjuvant CHT +/- RT followed by Sx
.
.

Metastatic Disease: CHT +/- IO +/- Palliative Rx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prostatic Urethra

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Surgery

A

Sx resections + Inguinal LND, no data for SLNB

17
Q

Chemotherapy

A

Urothelial Ca: Gem + Cisplatin or ddMVAC
.
.
SCCa: 5FU + Cisplatin or 5FU + MMC

18
Q

What needs to be done prior to RT

A

Circumcision to prevent Phimosis/Balanitis

19
Q

What settings can RT be done

A

Neoadjuvant, definitive, adjuvant or palliative

20
Q

When is Definitive radiation done

A

Organ preservation
T1-T2

21
Q

When is adjuvant RT done

A

T3-T4 disease
+ve margins

22
Q

RT

A

4500-5040 cGy EBRT to primary site, inguinal LN , Ext/int iliac nodes
.
.

Brachytherapy: 20-25Gy after EBRT for larger tumors

23
Q

CT Sim

A
24
Q

Dose Constrains

A
25
Q

Prognosis

A

OS:
3yrs - 55%
5yrs - 40-55%
10 yrs - 25-30%